Estrogen and phorbol esters regulate amphiregulin expression by two separate mechanisms in human breast cancer cell lines

I. Martinez-Lacaci, M. Saceda, G. D. Plowman, G. R. Johnson, N. Normanno, D. S. Salomon, R. B. Dickson

Research output: Contribution to journalArticle

Abstract

The actions of 17β-estradiol (E2) and protein kinase C (PKC) appear to converge in the regulation of expression of certain growth modulatory genes, such as the growth factor amphiregulin (AR). AR is known to modulate cell growth by binding to the epidermal growth factor receptor. In the current report we established the mechanisms of the PKC-activating phorbol ester tumor promoter, 12-O-tetradecanoylphorbol-13-acetate (TPA) and the steroid hormone E2 on the induction of AR expression in human breast carcinoma cell lines. TPA (100 nM) and E2 (1 nM) induce AR messenger RNA (mRNA) expression by 6- to 8-fold and 3- to 6-fold, respectively, in a time- and dose-dependent manner. In addition, immunoreactive AR protein is induced by both TPA and E2 by 6- to 8-fold and 2- to 4-fold, respectively. The PKC-modulating drugs, bryostatin and H-7, and antiestrogens(ICI 164,384 and 4-hydroxytamoxifen) interfere with AR induction by TPA and estrogen, respectively. The effects of TPA and E2 on the induction of AR mRNA were both closely associated with enhanced transcription of the AR gene. However, TPA had an additional effect at the posttranscriptional level by stabilizing the AR mRNA. The protein synthesis inhibitor, cycloheximide, prevented AR induction by TPA, suggesting that a component of the TPA induction of AR is indirect and dependent upon protein synthesis. Conversely, the E2 induction of AR transcription was found to be a direct response, independent of protein synthesis. The results presented herein thus demonstrate that TPA and E2 are able to stimulate AR gene transcription by two separate mechanisms.

Original languageEnglish
Pages (from-to)3983-3992
Number of pages10
JournalEndocrinology
Volume136
Issue number9
Publication statusPublished - 1995

Fingerprint

Phorbol Esters
Estrogens
Tetradecanoylphorbol Acetate
Breast Neoplasms
Cell Line
Protein Kinase C
Amphiregulin
Messenger RNA
Bryostatins
Genes
1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine
Proteins
Protein Synthesis Inhibitors
Estrogen Receptor Modulators
Cycloheximide
Growth
Epidermal Growth Factor Receptor
Carcinogens
Estradiol
Intercellular Signaling Peptides and Proteins

ASJC Scopus subject areas

  • Endocrinology
  • Endocrinology, Diabetes and Metabolism

Cite this

Martinez-Lacaci, I., Saceda, M., Plowman, G. D., Johnson, G. R., Normanno, N., Salomon, D. S., & Dickson, R. B. (1995). Estrogen and phorbol esters regulate amphiregulin expression by two separate mechanisms in human breast cancer cell lines. Endocrinology, 136(9), 3983-3992.

Estrogen and phorbol esters regulate amphiregulin expression by two separate mechanisms in human breast cancer cell lines. / Martinez-Lacaci, I.; Saceda, M.; Plowman, G. D.; Johnson, G. R.; Normanno, N.; Salomon, D. S.; Dickson, R. B.

In: Endocrinology, Vol. 136, No. 9, 1995, p. 3983-3992.

Research output: Contribution to journalArticle

Martinez-Lacaci, I, Saceda, M, Plowman, GD, Johnson, GR, Normanno, N, Salomon, DS & Dickson, RB 1995, 'Estrogen and phorbol esters regulate amphiregulin expression by two separate mechanisms in human breast cancer cell lines', Endocrinology, vol. 136, no. 9, pp. 3983-3992.
Martinez-Lacaci, I. ; Saceda, M. ; Plowman, G. D. ; Johnson, G. R. ; Normanno, N. ; Salomon, D. S. ; Dickson, R. B. / Estrogen and phorbol esters regulate amphiregulin expression by two separate mechanisms in human breast cancer cell lines. In: Endocrinology. 1995 ; Vol. 136, No. 9. pp. 3983-3992.
@article{82e066fbdd37488ea1141922eede8a92,
title = "Estrogen and phorbol esters regulate amphiregulin expression by two separate mechanisms in human breast cancer cell lines",
abstract = "The actions of 17β-estradiol (E2) and protein kinase C (PKC) appear to converge in the regulation of expression of certain growth modulatory genes, such as the growth factor amphiregulin (AR). AR is known to modulate cell growth by binding to the epidermal growth factor receptor. In the current report we established the mechanisms of the PKC-activating phorbol ester tumor promoter, 12-O-tetradecanoylphorbol-13-acetate (TPA) and the steroid hormone E2 on the induction of AR expression in human breast carcinoma cell lines. TPA (100 nM) and E2 (1 nM) induce AR messenger RNA (mRNA) expression by 6- to 8-fold and 3- to 6-fold, respectively, in a time- and dose-dependent manner. In addition, immunoreactive AR protein is induced by both TPA and E2 by 6- to 8-fold and 2- to 4-fold, respectively. The PKC-modulating drugs, bryostatin and H-7, and antiestrogens(ICI 164,384 and 4-hydroxytamoxifen) interfere with AR induction by TPA and estrogen, respectively. The effects of TPA and E2 on the induction of AR mRNA were both closely associated with enhanced transcription of the AR gene. However, TPA had an additional effect at the posttranscriptional level by stabilizing the AR mRNA. The protein synthesis inhibitor, cycloheximide, prevented AR induction by TPA, suggesting that a component of the TPA induction of AR is indirect and dependent upon protein synthesis. Conversely, the E2 induction of AR transcription was found to be a direct response, independent of protein synthesis. The results presented herein thus demonstrate that TPA and E2 are able to stimulate AR gene transcription by two separate mechanisms.",
author = "I. Martinez-Lacaci and M. Saceda and Plowman, {G. D.} and Johnson, {G. R.} and N. Normanno and Salomon, {D. S.} and Dickson, {R. B.}",
year = "1995",
language = "English",
volume = "136",
pages = "3983--3992",
journal = "Endocrinology",
issn = "0013-7227",
publisher = "The Endocrine Society",
number = "9",

}

TY - JOUR

T1 - Estrogen and phorbol esters regulate amphiregulin expression by two separate mechanisms in human breast cancer cell lines

AU - Martinez-Lacaci, I.

AU - Saceda, M.

AU - Plowman, G. D.

AU - Johnson, G. R.

AU - Normanno, N.

AU - Salomon, D. S.

AU - Dickson, R. B.

PY - 1995

Y1 - 1995

N2 - The actions of 17β-estradiol (E2) and protein kinase C (PKC) appear to converge in the regulation of expression of certain growth modulatory genes, such as the growth factor amphiregulin (AR). AR is known to modulate cell growth by binding to the epidermal growth factor receptor. In the current report we established the mechanisms of the PKC-activating phorbol ester tumor promoter, 12-O-tetradecanoylphorbol-13-acetate (TPA) and the steroid hormone E2 on the induction of AR expression in human breast carcinoma cell lines. TPA (100 nM) and E2 (1 nM) induce AR messenger RNA (mRNA) expression by 6- to 8-fold and 3- to 6-fold, respectively, in a time- and dose-dependent manner. In addition, immunoreactive AR protein is induced by both TPA and E2 by 6- to 8-fold and 2- to 4-fold, respectively. The PKC-modulating drugs, bryostatin and H-7, and antiestrogens(ICI 164,384 and 4-hydroxytamoxifen) interfere with AR induction by TPA and estrogen, respectively. The effects of TPA and E2 on the induction of AR mRNA were both closely associated with enhanced transcription of the AR gene. However, TPA had an additional effect at the posttranscriptional level by stabilizing the AR mRNA. The protein synthesis inhibitor, cycloheximide, prevented AR induction by TPA, suggesting that a component of the TPA induction of AR is indirect and dependent upon protein synthesis. Conversely, the E2 induction of AR transcription was found to be a direct response, independent of protein synthesis. The results presented herein thus demonstrate that TPA and E2 are able to stimulate AR gene transcription by two separate mechanisms.

AB - The actions of 17β-estradiol (E2) and protein kinase C (PKC) appear to converge in the regulation of expression of certain growth modulatory genes, such as the growth factor amphiregulin (AR). AR is known to modulate cell growth by binding to the epidermal growth factor receptor. In the current report we established the mechanisms of the PKC-activating phorbol ester tumor promoter, 12-O-tetradecanoylphorbol-13-acetate (TPA) and the steroid hormone E2 on the induction of AR expression in human breast carcinoma cell lines. TPA (100 nM) and E2 (1 nM) induce AR messenger RNA (mRNA) expression by 6- to 8-fold and 3- to 6-fold, respectively, in a time- and dose-dependent manner. In addition, immunoreactive AR protein is induced by both TPA and E2 by 6- to 8-fold and 2- to 4-fold, respectively. The PKC-modulating drugs, bryostatin and H-7, and antiestrogens(ICI 164,384 and 4-hydroxytamoxifen) interfere with AR induction by TPA and estrogen, respectively. The effects of TPA and E2 on the induction of AR mRNA were both closely associated with enhanced transcription of the AR gene. However, TPA had an additional effect at the posttranscriptional level by stabilizing the AR mRNA. The protein synthesis inhibitor, cycloheximide, prevented AR induction by TPA, suggesting that a component of the TPA induction of AR is indirect and dependent upon protein synthesis. Conversely, the E2 induction of AR transcription was found to be a direct response, independent of protein synthesis. The results presented herein thus demonstrate that TPA and E2 are able to stimulate AR gene transcription by two separate mechanisms.

UR - http://www.scopus.com/inward/record.url?scp=0029092283&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0029092283&partnerID=8YFLogxK

M3 - Article

C2 - 7649107

AN - SCOPUS:0029092283

VL - 136

SP - 3983

EP - 3992

JO - Endocrinology

JF - Endocrinology

SN - 0013-7227

IS - 9

ER -